ArticleEndocrine2024
SQSTM1/p62 is a prognostic molecular marker and potential therapeutic target for pancreatic neuroendocrine tumours.
Yu-Li Song et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleEndocrine2024
Yu-Li Song et al.PubMed ↗Publisher ↗
No numbers read from the abstract.